13D/G large-stake feed

Latest 13D/G Reports

Since 06 May 2026. Review filer CIK, subject security, ownership %, and SEC evidence first.

Recent 13D/G signals

Large-stake disclosures to inspect

Start with holder, issuer/security, stake size, and SEC evidence.

13G/A

ARMISTICE CAPITAL, LLC stake in LM FUNDING AMERICA, INC.

Holder CIK 0001601086

13G/A LMFA
CIK
0001601086
Issuer
LM FUNDING AMERICA, INC.
Security
LMFA
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
10% / 1,661,395 shares
Filed
15 May 2026, 11:28:40 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

ARMISTICE CAPITAL, LLC stake in Li-Cycle Holdings Corp.

Holder CIK 0001601086

13G/A LICY
CIK
0001601086
Issuer
Li-Cycle Holdings Corp.
Security
LICY
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
10% / 4,569,327 shares
Filed
15 May 2026, 11:27:50 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

CHOW TAI FOOK CAPITAL Ltd stake in Ivanhoe Electric Inc.

Holder CIK 0001962001

13G/A IE
CIK
0001962001
Issuer
Ivanhoe Electric Inc.
Security
IE
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
4% / 6,405,664 shares
Filed
15 May 2026, 11:27:22 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G

ARMISTICE CAPITAL, LLC stake in SANGAMO THERAPEUTICS, INC.

Holder CIK 0001601086

13G SGMO
CIK
0001601086
Issuer
SANGAMO THERAPEUTICS, INC
Security
SGMO
Source
SEC 13G
Action
Beneficial ownership disclosure
Magnitude
9.8% / 40,400,067 shares
Filed
15 May 2026, 11:27:12 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

ARMISTICE CAPITAL, LLC stake in KYNTRA BIO, INC.

Holder CIK 0001601086

13G/A FGEN
CIK
0001601086
Issuer
KYNTRA BIO, INC.
Security
FGEN
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
9.9% / 400,000 shares
Filed
15 May 2026, 11:27:06 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

ARMISTICE CAPITAL, LLC stake in KURA ONCOLOGY, INC.

Holder CIK 0001601086

13G/A KURA
CIK
0001601086
Issuer
Kura Oncology, Inc.
Security
KURA
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
4.2% / 3,736,000 shares
Filed
15 May 2026, 11:26:19 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

Rows shown
1,701-1,750 of 4,113
Per page
50
Current page
35

Schedule 13D/G ownership events

Activist and large-stake radar

Stake size, change direction, reporting filer, issuer, active/passive form type, and SEC evidence.

Visible reports

6

Fresh large-stake filings promoted above the legacy table.

13D/13G mix

0/6

Active-intent candidates versus passive large-stake disclosures.

Largest visible stake

10%

Highest class ownership surfaced in the preview cards.

Newest evidence

15 May 2026

Use recency before treating an old large-stake story as fresh.

Signal checks

13D active-intent check

active/control intent, item text, amendments

13G passive stake check

large passive holder disclosure

Stake change direction

ownership percent and share change

Issuer and owner follow-up

issuer, filer history, insider activity, 13F context

SEC-verifiable Schedule 13D/G path

Open the Schedule 13D/G filing, then cross-check insider and Form 13F evidence.

Large-stake signal

ARMISTICE CAPITAL, LLC

LM FUNDING AMERICA, INC. (LMFA)

Schedule 13G/A Ownership 10% Filing-backed
CIK
000117266126002168
Source
SEC Schedule 13G/A
Action
Large beneficial ownership stake disclosed
Magnitude
10%
Filed
15 May 2026, 11:28:40 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G/A for LM FUNDING AMERICA, INC. (LMFA). Reported class ownership: 10%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

ARMISTICE CAPITAL, LLC

Li-Cycle Holdings Corp. (LICY)

Schedule 13G/A Ownership 10% Filing-backed
CIK
000117266126002167
Source
SEC Schedule 13G/A
Action
Large beneficial ownership stake disclosed
Magnitude
10%
Filed
15 May 2026, 11:27:50 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G/A for Li-Cycle Holdings Corp. (LICY). Reported class ownership: 10%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

CHOW TAI FOOK CAPITAL Ltd

Ivanhoe Electric Inc. (IE)

Schedule 13G/A Ownership 4% Filing-backed
CIK
000147083126000449
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
4%
Filed
15 May 2026, 11:27:22 UTC
Period
15 May 2026

CHOW TAI FOOK CAPITAL Ltd filed Schedule 13G/A for Ivanhoe Electric Inc. (IE). Reported class ownership: 4%. Ownership change: -3.7%. Share change: -38%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

ARMISTICE CAPITAL, LLC

SANGAMO THERAPEUTICS, INC. (SGMO)

Schedule 13G Ownership 9.8% Filing-backed
CIK
000117266126002166
Source
SEC Schedule 13G
Action
Large beneficial ownership stake disclosed
Magnitude
9.8%
Filed
15 May 2026, 11:27:12 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G for SANGAMO THERAPEUTICS, INC. (SGMO). Reported class ownership: 9.8%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

ARMISTICE CAPITAL, LLC

KYNTRA BIO, INC. (FGEN)

Schedule 13G/A Ownership 9.9% Filing-backed
CIK
000117266126002165
Source
SEC Schedule 13G/A
Action
Large stake increase disclosed
Magnitude
9.9%
Filed
15 May 2026, 11:27:06 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G/A for KYNTRA BIO, INC. (FGEN). Reported class ownership: 9.9%. Ownership change: +1.5%. Share change: -95%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

ARMISTICE CAPITAL, LLC

KURA ONCOLOGY, INC. (KURA)

Schedule 13G/A Ownership 4.2% Filing-backed
CIK
000117266126002164
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
4.2%
Filed
15 May 2026, 11:26:19 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G/A for KURA ONCOLOGY, INC. (KURA). Reported class ownership: 4.2%. Ownership change: -1.4%. Share change: -24%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Filed by Symbol Subject Shares owned Ownership % Source
ARMISTICE CAPITAL, LLC CIK 0001601086 LMFA LM FUNDING AMERICA, INC. 1,661,395 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 LICY Li-Cycle Holdings Corp. 4,569,327 10% SEC filing
CHOW TAI FOOK CAPITAL Ltd CIK 0001962001 IE Ivanhoe Electric Inc. 6,405,664 4% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 SGMO SANGAMO THERAPEUTICS, INC. 40,400,067 9.8% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 FGEN KYNTRA BIO, INC. 400,000 9.9% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 KURA KURA ONCOLOGY, INC. 3,736,000 4.2% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 IVF INVO FERTILITY, INC. 371,562 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 SNAX STRYVE FOODS, INC. 397,085 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 CYTH IRONWOOD PHARMACEUTICALS, INC. 15,028,000 9.2% SEC filing
Radoff Bradley Louis CIK 0001380585 RHEP REGIONAL HEALTH PROPERTIES, INC 392,646 9.8% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 INBS INTELLIGENT BIO SOLUTIONS INC. 163,571 10% SEC filing
JANUS HENDERSON GROUP PLC CIK 0001274173 ARDX ARDELYX, INC. 8,371,234 3.4% SEC filing
JANUS HENDERSON GROUP PLC CIK 0001274173 OSIS OSI SYSTEMS, INC. 772,314 4.7% SEC filing
JANUS HENDERSON GROUP PLC CIK 0001274173 RVMD REVOLUTION MEDICINES, INC. 9,766,496 4.9% SEC filing
JANUS HENDERSON GROUP PLC CIK 0001274173 XENE XENON PHARMACEUTICALS INC. 4,175,982 4.5% SEC filing
JANUS HENDERSON GROUP PLC CIK 0001274173 SSNC SS&C TECHNOLOGIES HOLDINGS, INC. 8,425,246 3.5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 SOBR SOBR SAFE, INC. 147,403 5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 IMNN Imunon, Inc. 396,718 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 IINN INSPIRA TECHNOLOGIES OXY B.H.N. LTD. 4,343,252 10% SEC filing
BlueCrest Capital Management Ltd CIK 0001610880 CRTO Criteo S.A. 2,260,000 4.5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 SQFT Presidio Property Trust, Inc. 75,718 5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 HCWB HCW Biologics Inc. 353,680 5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 GOVX GEOVAX LABS, INC. 291,155 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 TMCI Treace Medical Concepts, Inc. 6,364,000 9.8% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 GCTK GLUCOTRACK, INC. 102,115 5% SEC filing
Caligan Partners LP CIK 0001727492 SABS SAB Biotherapeutics, Inc. 7,967,207 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 TVTX TRAVERE THERAPEUTICS, INC. 4,897,417 5.3% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 ESLA ESTRELLA IMMUNOPHARMA, INC. 4,280,375 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 VRAX Virax Biolabs Group Limited 1,000,239 5% SEC filing
ROYAL BANK OF CANADA CIK 0001000275 LBRDP Liberty Broadband Corporation 331,996 4.6% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 EKSO Ekso Bionics Holdings, Inc. 187,151 5% SEC filing
ROYAL BANK OF CANADA CIK 0001000275 OBE OBSIDIAN ENERGY LTD 4,415,055 6.6% SEC filing
ROYAL BANK OF CANADA CIK 0001000275 WELPP Wisconsin Electric Power Company 19,103 7.4% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 DWTX DOGWOOD THERAPEUTICS, INC. 3,343,120 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 VSEE VSee Health, Inc. 4,861,392 10% SEC filing
Solas Capital Management, LLC CIK 0001604867 MODD Modular Medical, Inc. 464,850 9.6% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 CYCU Cycurion, Inc. 289,388 5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 CTOR Citius Oncology, Inc. 9,299,917 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 CRIS Curis, Inc. 679,033 5% SEC filing
Chernett Jorey CIK 0002042077 WW WW INTERNATIONAL, INC. 507,356 5.1% SEC filing
PETTYJOHN, WOOD & WHITE, INC CIK 0001128213 BOTJ BANK OF THE JAMES FINANCIAL GROUP INC 224,259 4.9% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 CLDI CALIDI BIOTHERAPEUTICS, INC. 1,111,732 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 BTAI BioXcel Therapeutics, Inc. 1,910,076 7% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 BJDX Bluejay Diagnostics, Inc. 51,061 5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 VSTM Verastem, Inc. 4,592,000 5.2% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 BDRX Biodexa Pharmaceuticals Plc 187,975 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 BCYC Bicycle Therapeutics plc 3,398,000 6.8% SEC filing
Cliffwater Corporate Lending Fund CIK 0001735964 CUSIP 06763A101 Barings Private Credit Corporation 42,041,303 29% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 AVNS AVANOS MEDICAL, INC. 2,000,000 4.3% SEC filing
Solas Capital Management, LLC CIK 0001604867 MAIA MAIA Biotechnology, Inc. 4,297,004 7.1% SEC filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .